Dr. Rachel Elizabeth Ward, MD

Dr. Ward practices at Lifetime Skin Care Centers in Muncie, Indiana.

Dr. Ward's NPI, 1710373378, was assigned on April 10, 2015. Dr. Ward graduated from Indiana University School of Medicine in 2015. Dr. Ward holds Indiana license 01087224AA.

Dr. Ward's primary practice is Lifetime Skin Care Centers, at 401 W McGalliard Rd, Muncie, IN 47303 in Delaware County. The practice phone is (765) 288-6200.

Dr. Ward's primary practice is Lifetime Skin Care Centers in Muncie, Indiana. Dr. Ward is also affiliated with IU Health Ball Memorial Hospital. The medical group on file is Lifetime Skin Care Centers. Dmand AI also links Dr. Ward to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ward practices, 3 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Ward's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Ward is licensed in Indiana.

CMS data shows 1,662 Medicare services from Dr. Ward across 19 procedure codes in 2024, for 625 Medicare patients. Medicare paid $484,469 for them. Every service was in an office.

CMS counts 625 Medicare patients who saw Dr. Ward in 2024. The largest group is 75 to 84, with 270 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ward's median patient age at 77, with 42% women.

In 2024, Dr. Ward wrote 401 Medicare Part D claims for 280 patients. 96% of them were for generic drugs. CMS names the drug for 347 of them, across 4 drugs with 11 or more claims each, at $2,541 in total drug cost. In 2023, CMS named 317 claims across 4 drugs.

Dr. Ward accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 49 procedures of melanoma (skin cancer) excision by Dr. Ward, more than 86% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Ward, published from 2015 to 2024. 2015 was the busiest year, with 2. The most frequent topics are Skin Neoplasms. Dr. Ward has published most often in Am J Dermatopathol. Dr. Ward's most frequent co-authors are Darius R. Mehregan, MD, Jeffrey B. Travers, MD, PhD and Stefanie A. Ali, MD.

Dmand AI links Dr. Ward to 2 clinical trials. Conditions studied include Hidradenitis Suppurativa, pseudofolliculitis barbae and Hidradenitis. Wayne State University sponsors the most, 2.

CMS Open Payments shows 33 general payments to Dr. Ward from 15 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 79% of the total. MIMEDX Group, Inc. paid the most, $8,545.

Dr. Ward graduated from Indiana University School of Medicine in 2015.